ERBB2 and neoplasm: When analyzed for RNAseq-based tumor intrinsic subtype on the combined cohort, most tumors were ERBB2 enriched (57.9%), followed by luminal B (15.0%), luminal A (9.9%), basal-like (8.8%), and normal-like (8.3%).